• BioCardia CEO Peter Altman buys $5,208 in company stock Investing.com Wed, 08 Jul 2026 20:14:25 GMT
• Form 4 Biocardia Inc For: 8 July By Investing.com Investing.com South Africa Wed, 08 Jul 2026 20:13:19 GMT
• Insider buy: BioCardia (NASDAQ: BCDA) CEO adds 5,400 shares Stock Titan Wed, 08 Jul 2026 19:31:09 GMT
• BioCardia (BCDA) director receives 8,000 stock options exercisable at $1.20 Stock Titan Wed, 08 Jul 2026 02:16:35 GMT
• BioCardia (BCDA) CFO awarded 41,501 options; shares withheld for tax Stock Titan Wed, 08 Jul 2026 02:16:35 GMT
• BioCardia (BCDA) director Marvin Slosman awarded 8,000 stock options at $1.20 Stock Titan Wed, 08 Jul 2026 02:16:35 GMT
• BioCardia (BCDA) director granted 8,000 stock options at $1.20 Stock Titan Wed, 08 Jul 2026 02:16:35 GMT
• BioCardia (BCDA) director Andrew Blank awarded 8,000 stock options at $1.20 Stock Titan Wed, 08 Jul 2026 02:16:35 GMT
• BioCardia (BCDA) director Bill Facteau awarded 8,000 stock options at $1.20 Stock Titan Wed, 08 Jul 2026 02:16:34 GMT
• BioCardia (BCDA) CEO Altman has RSU tax shares withheld, receives new option grant Stock Titan Wed, 08 Jul 2026 02:16:34 GMT
• Form 4 Biocardia Inc For: 7 July By Investing.com Investing.com India Wed, 08 Jul 2026 01:51:21 GMT
• BioCardia (BCDA) SVP granted 29,442 options and has RSU shares withheld for taxes Stock Titan Mon, 06 Jul 2026 07:00:00 GMT
• Form 4 Biocardia Inc For: 1 July By Investing.com Investing.com Canada Thu, 02 Jul 2026 00:07:08 GMT
• BioCardia (BCDA) CEO Peter Altman granted 110,625 fully vested RSUs Stock Titan Wed, 01 Jul 2026 23:38:24 GMT
• BioCardia (BCDA) CFO granted 60,483 RSUs as stock compensation Stock Titan Wed, 01 Jul 2026 23:37:58 GMT
• BioCardia (BCDA) SVP awarded 39,521 RSUs fully vesting on June 29, 2026 Stock Titan Wed, 01 Jul 2026 23:37:47 GMT
• BioCardia Inc (BCDA) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Wed, 01 Jul 2026 07:00:00 GMT
• BioCardia (BCDA) Slips 2.48% as Stock Tests Key Support Near $1.12 - High Reward Trades dars.gov.et Tue, 30 Jun 2026 07:00:00 GMT
• Price to earnings forward of BioCardia, Inc. – NASDAQ:BCDA TradingView Thu, 25 Jun 2026 14:23:05 GMT
• biocardia inc (bcda) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 10:17:30 GMT
• form 4 biocardia inc for: 24 june by investing.com Investing.com India Thu, 25 Jun 2026 07:00:00 GMT
• biocardia director simon stertzer buys $103,584 in common stock Investing.com UK Thu, 25 Jun 2026 01:26:27 GMT
• Form 4 Biocardia Inc For: 24 June By Investing.com Investing.com Nigeria Wed, 24 Jun 2026 23:00:51 GMT
• Director Stertzer (BCDA) adds 109,200 BioCardia shares in open-market buys Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• BioCardia director Simon Stertzer buys $103,584 in common stock Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• biocardia inc (bcda) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• form 4 biocardia inc for: 22 june by investing.com Investing.com Australia Mon, 22 Jun 2026 10:27:22 GMT
• BioCardia president & CEO Peter Altman buys $2,043 in stock By Investing.com Investing.com UK Mon, 22 Jun 2026 10:14:00 GMT
• BioCardia (BCDA) CEO adds 2,300 shares in open-market buys Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• biocardia inc (bcda) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• biocardia (bcda) moves higher near resistance – testing key levels - momentum stock picks dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• biocardia outlines 2026 strategic priorities: japan cardiamp submission, u.s. expansion, and new partnership opportunities – minic... Minichart Thu, 18 Jun 2026 14:26:00 GMT
• biocardia inc (bcda) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 12:59:52 GMT
• biocardia letter to stockholders on 2026 priorities and strategic opportunities 富途牛牛 Thu, 18 Jun 2026 12:00:00 GMT
• biocardia's high-stakes gambit: a japan-first strategy for heart therapy BriefGlance Thu, 18 Jun 2026 12:00:00 GMT
• BioCardia plans Japan regulatory submission for heart therapy Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• BioCardia targets Japan PMDA submission for CardiAMP, advances U.S. trial and partnership opportunities TradingView Thu, 18 Jun 2026 07:00:00 GMT
• BioCardia (NASDAQ: BCDA) details Japan approval push and 2026 catalysts Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• BioCardia (BCDA) Shares Strategic Business Update Following Capi GuruFocus Thu, 18 Jun 2026 07:00:00 GMT
• biocardia says japan filing, u.s. trial enrollment top 2026 priorities Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• biocardia inc (bcda) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 01:01:04 GMT
• biocardia inc (bcda) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:34:48 GMT
• biocardia inc (bcda) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 20:56:17 GMT
• BioCardia Inc (BCDA) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey Wed, 17 Jun 2026 20:53:50 GMT
• biocardia inc (bcda) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 19:23:41 GMT
• biocardia inc (bcda) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 18:55:05 GMT
• biocardia inc (bcda) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:23:08 GMT
• biocardia inc (bcda) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• biocardia inc (bcda) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• biocardia inc (bcda) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• biocardia inc (bcda) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• BioCardia Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView Fri, 12 Jun 2026 07:00:00 GMT
• BCDA Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances Clinical Pipeline - Earnings Sentiment Score dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• biocardia (nasdaq: bcda) raises $4.9m and updates nasdaq listing compliance Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• biocardia shares rally after fda supports regulatory path for heart failure therapy (bcda) MSN Fri, 12 Jun 2026 04:05:45 GMT
• biocardia shares rally after fda supports regulatory path for heart failure therapy (bcda) MSN Wed, 10 Jun 2026 12:34:56 GMT
• analysts offer insights on healthcare companies: nuvalent (nuvl), lyell immunopharma (lyel) and biocardia (bcda) The Globe and Mail Wed, 10 Jun 2026 07:00:00 GMT
• bcda reiterated by hc wainwright & co. -- price target maintained at $25 GuruFocus Wed, 10 Jun 2026 04:04:40 GMT
• bcda reiterated by hc wainwright & co. -- price target maintained at $25 GuruFocus Tue, 09 Jun 2026 11:17:10 GMT
• BioCardia raises $4.4 million in financing for its heart failure cell therapies Cardiovascular Business Tue, 09 Jun 2026 07:00:00 GMT
• biocardia (bcda) ceo peter altman adds 5,000 shares in open-market buy Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• biocardia ceo peter altman buys $4,250 in company stock Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• biocardia raises $4.4 million to extend cash runway The Globe and Mail Tue, 09 Jun 2026 07:00:00 GMT
• biocardia shares rally after fda supports regulatory path for heart failure therapy (bcda) MSN Mon, 08 Jun 2026 13:06:24 GMT
• biocardia's $4.4m lifeline: fuel for japan, but for how long? BriefGlance Mon, 08 Jun 2026 12:00:00 GMT
• BioCardia $4.4M raise to extend runway past Japan PMDA submission into 2027 Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• BioCardia (NASDAQ: BCDA) extends cash runway with $4.4M equity raise Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• BioCardia, Inc. Raises $4.48 Million to Extend Cash Runway into 2027 Ahead of PMDA Submission Quiver Quantitative Mon, 08 Jun 2026 07:00:00 GMT
• BioCardia sells 3.51M shares for $4.49M to extend cash runway into early 2027 TradingView Mon, 08 Jun 2026 07:00:00 GMT
• Biocardia raises $4.5 million through share sale By Investing.com Investing.com Canada Mon, 08 Jun 2026 07:00:00 GMT
• BioCardia Announces $4.4 Million Financing to Extend Cash Runway Into 2027 and Support Japan PMA Submission 9 Minichart Mon, 08 Jun 2026 07:00:00 GMT
• BCDA Stock Surges As FDA Softens Trial Requirements For CardiAMP timothysykes.com Sun, 07 Jun 2026 07:00:00 GMT
• bcda surges as biocardia wins key fda trial breakthrough StocksToTrade Sat, 06 Jun 2026 23:22:00 GMT
• biocardia shares rally after fda supports regulatory path for heart failure therapy (bcda) MSN Sat, 06 Jun 2026 06:43:53 GMT
• biotech movers: biocardia surges on fda meeting minutes, clearmind hits trial milestone, nuwellis slides on offering Investorideas.com Fri, 05 Jun 2026 16:51:44 GMT
• biocardia fda update: cardiamp trial could support pma approval grafa.com Fri, 05 Jun 2026 16:24:00 GMT
• $biocardia (bcda.us)$ all in all..got a good trade..big profits..but thats all for now..gl all Moomoo Fri, 05 Jun 2026 16:09:48 GMT
• biocardia’s cardiamp hf ii clinical trial may support fda premarket approval for cell therapy in heart failure Minichart Fri, 05 Jun 2026 14:15:00 GMT
• fda confirms cardiamp hf ii may support premarket approval of cardiamp cell therapy for ischemic hfref Moomoo Fri, 05 Jun 2026 12:00:00 GMT
• BioCardia Shares Rally After FDA Supports Regulatory Path for Heart Failure Therapy (BCDA) Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• FDA minutes support BioCardia (NASDAQ: BCDA) CardiAMP HF II PMA pathway Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• BioCardia® Receives FDA Minutes Confirming Eligibility for Premarket Approval of CardiAMP Cell Therapy for Ischemic Heart Failure Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT
• BioCardia stock surges on FDA trial pathway confirmation Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• BioCardia receives FDA feedback on heart failure trial pathway Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• BioCardia jumps after FDA minutes clarify PMA path for CardiAMP HF II trial | BCDA Stock News Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT
• BCDA Stock Jumps As FDA Clears Path For Helix Catheter StocksToTrade Fri, 05 Jun 2026 07:00:00 GMT
• BCDA Stock Holds Key Support As FDA Clears Paths For Helix timothysykes.com Fri, 05 Jun 2026 07:00:00 GMT
• fda flags heart failure cell therapy trial that may aid 1m patients Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 05 Jun 2026 07:00:00 GMT
• biocardia (bcda) advances cardiamp cell therapy approval process GuruFocus Fri, 05 Jun 2026 07:00:00 GMT
• biocardia jumps after fda feedback seen positive for cardiamp approval TechStock² Fri, 05 Jun 2026 07:00:00 GMT
• Japan moves closer to approving BioCardia heart failure therapy Longevity.Technology Thu, 04 Jun 2026 07:00:00 GMT
• biocardia outlines japan shonin filing in ~7 months and targets ~19-month path to approval for cardiamp MSN Wed, 03 Jun 2026 07:33:18 GMT
• bcda stock price, quote & chart | biocardia inc (nasdaq:bcda) ChartMill Fri, 29 May 2026 07:00:00 GMT
• biocardia, inc. (bcda) files 8-k with sec: company details, stock info, and contact information (may 28, 2026) Minichart Thu, 28 May 2026 18:34:00 GMT
• BioCardia receives regulatory guidance from Japan’s PMDA By Investing.com Investing.com Nigeria Thu, 28 May 2026 07:00:00 GMT
• japan regulators back filing for cell therapy for 20,000 heart failure patients Stock Titan Thu, 28 May 2026 07:00:00 GMT
• biocardia announces japan pmda record of advice supports regulatory submission for approval of cardiamp cell therapy for ischemic ... The Manila Times Thu, 28 May 2026 07:00:00 GMT
• biocardia pmda consultation record supports q4 2026 submission for cardiamp in ischemic hfref TradingView Thu, 28 May 2026 07:00:00 GMT
• biocardia (nasdaq: bcda) wins pmda support to file cardiamp heart failure therapy in japan Stock Titan Thu, 28 May 2026 07:00:00 GMT
• biocardia’s cardiamp shows 179-second exercise gain in refractory angina trial The Clinical Trial Vanguard Mon, 25 May 2026 06:51:38 GMT
• biocardia outlines japan shonin filing in ~7 months and targets ~19-month path to approval for cardiamp MSN Sat, 23 May 2026 10:02:31 GMT
• biocardia ceo peter altman buys $1,570 in company stock by investing.com Investing.com India Fri, 22 May 2026 00:24:48 GMT
• biocardia announces positive cardiamp chronic myocardial ischemia trial results with reduced angina at europcr 2026 Minichart Thu, 21 May 2026 15:31:00 GMT
• BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercis... The Manila Times Thu, 21 May 2026 07:00:00 GMT
• heart cell therapy linked to longer walks, 82% fewer angina attacks Stock Titan Thu, 21 May 2026 07:00:00 GMT
• biocardia (nasdaq: bcda) posts cardiamp cmi data with durable angina and exercise gains Stock Titan Thu, 21 May 2026 07:00:00 GMT
• biocardia reports positive results from cardiamp cmi trial Investing.com Thu, 21 May 2026 07:00:00 GMT
• biocardia (nasdaq: bcda) ceo adds 1,700 shares in may open‑market buys Stock Titan Thu, 21 May 2026 07:00:00 GMT
• biocardia ceo peter altman buys $1,570 in company stock Investing.com Thu, 21 May 2026 07:00:00 GMT
• bcda: biocardia and barinthus advance late-stage therapies, targeting major approvals and market expansion TradingView Wed, 20 May 2026 17:31:45 GMT
• biocardia outlines japan shonin filing in ~7 months and targets ~19-month path to approval for cardiamp MSN Wed, 20 May 2026 05:49:10 GMT
• biocardia outlines japan shonin filing in ~7 months and targets ~19-month path to approval for cardiamp MSN Tue, 19 May 2026 18:59:02 GMT
• biocardia, inc. (nasdaq:bcda) q1 2026 earnings call transcript Insider Monkey Tue, 19 May 2026 12:16:59 GMT
• BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase The Manila Times Tue, 19 May 2026 07:00:00 GMT
• watch biocardia’s virtual fireside chat at a.g.p. healthcare showcase Stock Titan Tue, 19 May 2026 07:00:00 GMT
BioCardia, Inc(NASDAQ:BCDA) 
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmo...
Website: http://www.biocardia.com/
Full Time Employees: 20
CEO: Peter Altman
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends